ArticleACS medicinal chemistry letters2024

Discovery and Characterization of Active CBP/EP300 Degraders Targeting the HAT Domain.

Iván Cheng-Sánchez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.